The safety of enoxaparin in patients older than 60 years with acute myelogenous leukemia or high risk myelodysplastic syndrome undergoing chemotherapy
Joint Authors
Ukashah, Marwan S.
Abu Hajir, Majid
Source
Issue
Vol. 24, Issue 2 (30 Jun. 2002)4 p.
Publisher
King Hamad University Hospital
Publication Date
2002-06-30
Country of Publication
Bahrain
No. of Pages
4
Main Subjects
Topics
American Psychological Association (APA)
Ukashah, Marwan S.& Abu Hajir, Majid. 2002. The safety of enoxaparin in patients older than 60 years with acute myelogenous leukemia or high risk myelodysplastic syndrome undergoing chemotherapy. Bahrain Medical Bulletin،Vol. 24, no. 2.
https://search.emarefa.net/detail/BIM-602745
Modern Language Association (MLA)
Ukashah, Marwan S.& Abu Hajir, Majid. The safety of enoxaparin in patients older than 60 years with acute myelogenous leukemia or high risk myelodysplastic syndrome undergoing chemotherapy. Bahrain Medical Bulletin Vol. 24, no. 2 (Jun. 2002).
https://search.emarefa.net/detail/BIM-602745
American Medical Association (AMA)
Ukashah, Marwan S.& Abu Hajir, Majid. The safety of enoxaparin in patients older than 60 years with acute myelogenous leukemia or high risk myelodysplastic syndrome undergoing chemotherapy. Bahrain Medical Bulletin. 2002. Vol. 24, no. 2.
https://search.emarefa.net/detail/BIM-602745
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 4
Record ID
BIM-602745
